We further evaluated the PLEK2 expression in HNSCC subgroups compared with normal samples based on several clinicopathological features including gender, age, race, tumor grade, individual cancer stages, nodal metastasis status, HPV status, and TP53 status, alcohol, and tobacco smoking history in TCGA. The gene discussed is TP53; the disease is cancer.